Carrie Smith Cox insider trades

Open-market stock purchases and sales by Carrie Smith Cox, Director at Solventum Corp, from SEC Form 4 filings since Jan 28, 2010.

Track record: 80% of 5 scored buys are up 5% or more since purchase, averaging +32%.

Recent trades

DateStockTradeValue
May 15, 2026SOLV Solventum CorpBought (not open market)—
May 13, 2026TXN Texas Instruments IncSold$2.6M
May 13, 2026TXN Texas Instruments IncSold$137K
May 13, 2026TXN Texas Instruments IncBought (not open market)—
May 13, 2026TXN Texas Instruments IncBought (not open market)—
Apr 30, 2026SOLV Solventum CorpBought (not open market)—
Mar 27, 2026SOLV Solventum CorpBought (not open market)—
Jan 29, 2026TXN Texas Instruments IncBought (not open market)—
Jan 29, 2026TXN Texas Instruments IncBought (not open market)—
Nov 12, 2025OGN Organon & CoBought$502K

Companies traded

  • SOLV Solventum Corp: other filings, last May 15, 2026
  • TXN Texas Instruments Inc: 10 sales, last May 13, 2026
  • OGN Organon & Co: 2 buys, last Nov 12, 2025
  • RNAC Cartesian Therapeutics, Inc: other filings, last Jan 2, 2025
  • SELB Selecta Biosciences Inc: 2 buys, last Jan 2, 2023
  • CAH Cardinal Health Inc: 1 buy, last Nov 9, 2022
  • CELG Celgene Corp /de/: 1 buy, 1 sale, last Nov 20, 2019
  • ARRY Array Biopharma Inc: 2 buys, last Jul 30, 2019
  • ECOR electroCore, Inc: 4 buys, last Jun 7, 2019

Get free alerts when Carrie Smith Cox files a new trade →